Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients

被引:46
作者
Rosenbaum, C
Kluwe, L
Mautner, VF
Friedrich, RE
Muller, HW
Hanemann, CO
机构
[1] Univ Dusseldorf, Mol Neurobiol Lab, Dept Neurol, D-40225 Dusseldorf, Germany
[2] Univ Hosp Eppendorf, Dept Oral & Maxillofacial Surg, Hamburg, Germany
[3] Gen Hosp Ochsenzoll, Dept Neurol, Hamburg, Germany
[4] Univ Dusseldorf, Biol Med Res Ctr, D-4000 Dusseldorf, Germany
关键词
D O I
10.1006/nbdi.1998.0179
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromatosis type 2 (NF2) is an autosomal dominant disease of the nervous system characterized by multiple schwannomas. The NF2 gene product, termed schwannomin or merlin, was hypothesized to function as a cytoskeleton-membrane linking protein due to homology to members of the protein 4.1 superfamily and to function as a tumor suppressor. We isolated and characterized pure Schwann cell cultures from schwannomas derived from neurofibromatosis 2 patients with identified germline mutations and loss of heterozygosity. We describe striking differences between NF2 and control Schwann cells in morphology, cell-cell contacts, and growth. NF2 Schwann cells form multiple long processes with filopodial and lamellopodial extensions. NF2 Schwann cells lack contact inhibition, grow in multiple layers, and show a higher proliferation rate than control cells. For the first time Schwann cells derived from patients with the NF2 genotype were cultured and characterized in vitro. These cultures are highly valuable for investigating the effects of NF2 mutations and the development of therapies. (C) 1998 Academic Press.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 47 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   PROLIFERATIVE POTENTIAL OF SPORADIC AND NEUROFIBROMATOSIS 2-ASSOCIATED SCHWANNOMAS AS STUDIED BY MIB-1 (KI-67) AND PCNA LABELING [J].
ANTINHEIMO, J ;
HAAPASALO, H ;
SEPPALA, M ;
SAINIO, M ;
CARPEN, O ;
JAASKELAINEN, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (06) :776-782
[3]   PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO THE MAJOR PERIPHERAL MYELIN GLYCOPROTEIN-PO [J].
BOLLENSEN, E ;
SCHEIDT, P ;
SCHACHNER, M .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (04) :1110-1114
[4]   DIFFERENTIAL EXPRESSION OF 2 MESSENGER-RNA SPECIES INDICATES A DUAL FUNCTION OF PERIPHERAL MYELIN PROTEIN PMP22 IN CELL-GROWTH AND MYELINATION [J].
BOSSE, F ;
ZOIDL, G ;
WILMS, S ;
GILLEN, CP ;
KUHN, HG ;
MULLER, HW .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 37 (04) :529-537
[5]   GROWTH OF A RAT NEUROBLASTOMA CELL LINE IN SERUM-FREE SUPPLEMENTED MEDIUM [J].
BOTTENSTEIN, JE ;
SATO, GH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (01) :514-517
[7]   Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane [J].
Deguen, B ;
Mérel, P ;
Goutebroze, L ;
Giovannini, M ;
Reggio, H ;
Arpin, M ;
Thomas, G .
HUMAN MOLECULAR GENETICS, 1998, 7 (02) :217-226
[8]  
DENBAKKER MA, 1995, AM J PATHOL, V147, P1339
[9]  
DeVitis LR, 1996, HUM GENET, V97, P632
[10]  
GonzalezAgosti C, 1996, ONCOGENE, V13, P1239